Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Aug. 23, 2021

Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II

Aug. 23, 2021

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Aug. 23, 2021

AAV gene therapy targeting CaMKII protects retinal ganglion cells, preserves vision

Aug. 23, 2021

Improved serum metabolic profile and symptoms in patients with ALS treated with ILB

Aug. 23, 2021

Salicylanilide compounds show promise for treating COVID-19

Aug. 23, 2021

APP gene mutation causes autosomal dominant Alzheimer's disease

Aug. 23, 2021

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

Aug. 23, 2021

Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1

Aug. 23, 2021

New SREBP inhibitors identified at Capulus Therapeutics

Aug. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...